期刊文献+

机械辅助循环装置治疗心力衰竭的应用研究进展 被引量:1

Progress of the mechanical circulatory support devices application in the treatment of heart failure
原文传递
导出
摘要 心力衰竭(heart failure,HF)是各种心脏疾病的严重表现或晚期阶段,死亡率和再住院率居高不下。我国 HF 患病率呈持续升高趋势。《中国心血管健康与疾病报告2020》显示,我国有890万HF患者,其死亡率亦逐年上升。对于晚期HF患者,心脏移植仍然是最佳选择,但由于缺乏捐赠者,极大地影响了治疗方案和患者管理。因此,亟需高效且安全的替代疗法。现对心脏移植之前的机械辅助循环装置替代疗法及其最新研究和临床应用进展作一综述。 Heart failur(HF) is a severe manifestation or advanced stage of various heart diseases,with high mortality and re-hospitalization rates.The prevalence of HF continues to increase in China.According to “China Cardiovascular Health and Disease Report 2020”,there are 8.9 million HF patients in China,and the mortality rate is also increasing year by year.Heart transplant is still the best option for patients with advanced HF,but the lack of donors greatly affects treatment decision making and patient management.Therefore,efficient and safe alternative therapies are urgently needed.This paper reviewed the recent research and clinical application of mechanical assisted circulatory devices as an alternative therapy before heart transplantation.
作者 洪诗卉 伍锋 樊民 HONG Shihui;WU Feng;FAN Min(Department of Cardiology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China)
出处 《世界临床药物》 2022年第5期503-508,共6页 World Clinical Drug
基金 国家自然科学基金面上项目(82074266)。
关键词 机械辅助循环 心力衰竭 替代疗法 治疗 mechanical circulatory support heart failure replacement therapy treatment
  • 相关文献

参考文献5

二级参考文献72

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2吴广辉.轴流式心脏辅助装置及其发展现状[J].北京生物医学工程,2004,23(4):306-308. 被引量:5
  • 3徐晓佳,李帆.轴流式血泵的研究进展[J].北京生物医学工程,2005,24(5):394-397. 被引量:4
  • 4范慧敏,卢容,刘中民.国产植入型心室辅助装置的实验研究[J].同济大学学报(医学版),2006,27(5):6-9. 被引量:6
  • 5Timms D. A review of clinical ventricular assist devices [ J ]. Med Eng Phys, 2011, 33(9) : 1041 -1047.
  • 6Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not trans-plant candidates: results of the INTREPID trial [J]. J Am Coil Cardiol, 2007, 50:741 -747.
  • 7Nguycn DQ, Thourani VH. Third-generation continuous flow left ventricular assist devices [ J]. Innovations (Phila), 2010, 5 (4) : 250 -258.
  • 8Patel SM, Throekmorton AL, Untaroiu A, et al. The status of failure and reliability testing of artificial blood pumps [ J ]. ASAIO J, 2005, 51(4) : 440 -451.
  • 9Farrar D J, Bourque K, Dague CP, et al. Design features, developmental status, and experimental results with the Heartmate III centrifugal left ventricular assist system with a magnetically levitated rotor [ J ]. ASAIO J, 2007, 53 ( 3 ) : 310 315.
  • 10Wieselthaler GM, O Driscoll G, Jansz P, et al. Initial experience with a novel left ventricular assist device magnetically levitated rotor in a multi-institutional trial Heart Lung Transplant, 2010, 29 ( 11 ) : 1218 - 1225. clinical with a.

共引文献5158

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部